investigator's application): Smooth muscle cells have been the subject of intense study because abnormal growth and proliferation of vascular smooth muscle cells is involved in the pathogenesis of atherosclerosis and hypertension. In particular, the various proximal signals that influence growth and differentiation of SM-cells including growth factors and their receptors and the intracellular signaling pathways have been extensively investigated. However, the cellular and molecular basis of smooth muscle differentiation is poorly understood. With this standpoint a central question in vascular biology relates to understanding the transcriptional control mechanisms underlying smooth muscle differentiation and diversity. The Study of this subject has been impeded by the lack of smooth muscle cell differentiation. The investigators have recently isolated and characterized the smooth muscle myosin heavy chain (SMHC) gene promoter. They further demonstrated that SM-myosin is expressed exclusively in SM-cells and the SMHC gene promoter is transcribed only in the smooth muscle cells but not in other cell types. These results led us to hypothesize that the SMHC gene promoter contains cis-DNA elements which restrict its expression to SM-cells by interacting with a set of SM-cell specific trans-factors. Therefore, the primary goal of this project is to determine the factors which restrict SMHC gene expression to SM-cells using in vitro and in vivo gene transfer methodology. A second important goal is to identify the early steps in SM-cell differentiation using the SM-cell specific markers and the SMHC-gene linked to a LacZ reporter in transgenic mice. These studies proposed here will characterize a smooth muscle specific promoter which will allow us to deliver specific gene products into smooth muscle cells and study their role in SM-cell growth and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038355-14
Application #
6125759
Study Section
Physiology Study Section (PHY)
Program Officer
Lymn, Richard W
Project Start
1987-04-01
Project End
2001-05-31
Budget Start
1999-12-01
Budget End
2001-05-31
Support Year
14
Fiscal Year
2000
Total Cost
$289,538
Indirect Cost
Name
University of Cincinnati
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221